POZEN (POZN) Misses Q3 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
POZEN Reports Third Quarter 2015 Results
November 9, 2015 7:00 AM ESTStrategic Merger with Tribute Pharmaceuticals Still on Track to Close in December 2015
Commercial Launch Preparation Efforts for YOSPRALATM Well Underway
CHAPEL HILL, N.C.--(BUSINESS WIRE)-- POZEN Inc. (NASDAQ: POZN), today announced results for the third quarter ended September 30, 2015. The Company highlighted important corporate, commercial, and regulatory updates from the quarter.
Total revenues resulting from VIMOVO® royalties for the three month period ended September 30, 2015, were $5.8 million, compared to total revenues of $7.5 million in the third quarter of 2014 that included $5.5... More
